Effect of Time-restricted Eating on Cognitive Function and Other Biopsychosocial Factors in Menopausal Women Undertaking a 12-week Exercise Programme
NCT06138015, Not applicable, Completed, Poznan University of Physical Education
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effect of Time-restricted Eating on Cognitive Function and Other Biopsychosocial Factors in Menopausal Women Undertaking a 12-week Exercise Programme | ClinicalTrials.gov |
| NCT number | NCT06138015 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 80 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Poznan University of Physical Education | ClinicalTrials.gov |
| Conditions | Menopause, Cognitive Deficits, Mild | ClinicalTrials.gov |
| Interventions | Exercise and Time-Restricted Eating, Exercise only | ClinicalTrials.gov |
| First posted | 2023-11-18 | ClinicalTrials.gov |
| Last updated | 2023-11-18 | ClinicalTrials.gov |
Registered outcomes 14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Brain-derived neurotrophic factor | Before and after 12-week intervention | Level of brain-derived neurotrophic factor in ng/ml | ClinicalTrials.gov |
| Primary | Glial cell derived neurotrophic factor | Before and after 12-week intervention | Level of glial cell derived neurotrophic factor in ng/ml | ClinicalTrials.gov |
| Primary | Insulin | Before and after 12-week intervention | Level of insulin in μIU/ml | ClinicalTrials.gov |
| Primary | Glucose | Before and after 12-week intervention | Level of glucose in mg/dl | ClinicalTrials.gov |
| Primary | LDL-cholesterol | Before and after 12-week intervention | Level of cholesterol LDL in mg/dl | ClinicalTrials.gov |
| Primary | Muscle mass | Before and after 12-week intervention | Bioelectrical impedance analysis for estimating body composition, in particular muscle mass in kg | ClinicalTrials.gov |
| Primary | Fat mass | Before and after 12-week intervention | Bioelectrical impedance analysis for estimating body composition, in particular fat mass in kg | ClinicalTrials.gov |
| Primary | Stroop test | Before and after 12-week intervention | Cognitive functions assessment with Stroop test in points. Higher scores means better outcome. | ClinicalTrials.gov |
| Primary | N-back test | Before and after 12-week intervention | Cognitive functions assessment with N-back test in points. Higher scores means better outcome. | ClinicalTrials.gov |
| Primary | Electroencephalography | Before and after 12-week intervention | Measurement of brain waves (alpha, beta, gamma, theta) to assess electrical activity of the brain using Emotiv Epoc X device | ClinicalTrials.gov |
| Primary | One-repetition maximum test | Before and after 12-week intervention | Strength assessment with one-repetition maximum test in kg | ClinicalTrials.gov |
| Primary | Ruffier test | Before and after 12-week intervention | Cardiorespiratory fitness assessment with Ruffier test in points. Minimum value is 0, maximum value is 10. Higher score means worse outcome. | ClinicalTrials.gov |
| Primary | Menopause Rating Scale | Before and after 12-week intervention | Menopausal symptoms assessment with Menopause Rating Scale in points. Minimum value is 0 and maximum value is 44. Higher score means worse outcome. | ClinicalTrials.gov |
| Primary | The Menopause-Specific Quality of Life Questionnaire | Before and after 12-week intervention | Menopausal symptoms assessment with The Menopause-Specific Quality of Life Questionnaire in points. Minimum value is 0 and maximum value is 174. Higher score means worse outcome. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 2
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| 1-Back Task | Primary outcome | ConductCognition |
| 2-Back Task | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)